{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pulmonary-alveolar-proteinosis-with-hypogammaglobulinemia","columns":[{"gene":"","key":"population-b655efa100986cdfbf71","label":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","mondoId":"MONDO:0020840","onsetQualifier":null,"originColumnKey":"MONDO:0020840/OMIM:618042","originalViews":[{"key":"MONDO:0020840/OMIM:618042","label":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","scopeLabel":"OMIM:618042","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["151f7e88f3bbbce9281c476d5f4a61bb45e986e7d2b01fd3bd3b4affea0e8c8a","d4ca6ee8282ffa43d25fa37fc98a78cdfda487fc47426a7f58eea883e68c5da5","d82122cf73d804a7a18b84d7088ea5cd94c043cd4c6546aa9507d7f75dfd8595","d91e072fef96d8cb4ff151e4bdf3dc9e2c9454fcb695f5b100520c1c7a3f6359","e041f39ed502d902c03e5875ffe0ebf747731d5004573a61a7c07c69fd80a88d","fe60f5362c4e1f79818a752da28600d33d6dbf6d3a53319aecb31ab64987c5c9"],"recordQualifiers":{},"scopeLabel":"OMIM:618042","sourceIds":["OMIM:618042"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b655efa100986cdfbf71"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004313","HP:0001974","HP:0006517","HP:0002205","HP:0002093","HP:0001744"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"published":6}},"features":[{"hpoId":"HP:0004313","label":"Decreased circulating immunoglobulin concentration","primary":true},{"hpoId":"HP:0001974","label":"Increased total leukocyte count","primary":true},{"hpoId":"HP:0006517","label":"Intraalveolar phospholipid accumulation","primary":true},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":true},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":true},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":true}],"ledeHtml":"A primarily a lung disorder characterized by onset of respiratory insufficiency due to pulmonary alveolar proteinosis (PAP) in the first months of life. Affected individuals may have normal respiratory function at birth. Development of the disorder appears to be influenced or triggered by viral infection, manifest as progressive respiratory insufficiency, confluent consolidations on lung imaging, and diffuse collection of periodic acid-Schiff (PAS)-positive material in pulmonary alveoli associated with small and nonfoamy alveolar macrophages. Patients also have hypogammaglobulinemia, leukocytosis, and splenomegaly. Many patients die of respiratory failure in infancy or early childhood; hematopoietic stem cell transplantation (HSCT) is curative. The pathogenesis may be related to abnormal function of alveolar macrophages, resulting in decreased catabolism of surfactant. The disorder results from a gain-of-function effect that particularly affects B cells and monocytes.","mondoId":"MONDO:0020840","node":{"canonicalSlug":"pulmonary-alveolar-proteinosis-with-hypogammaglobulinemia","comparisons":[{"documentSha256":"ba906885a98782794e154ff1ae99f794946f663e6f601c7b55e0d63fde0369e9","key":"legacy-pulmonary-alveolar-proteinosis-with-hypogammaglobulinemia","kind":"legacy","label":"pulmonary alveolar proteinosis with hypogammaglobulinemia","memberIds":["MONDO:0020840"],"mondoId":"MONDO:0020840","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pulmonary-alveolar-proteinosis-with-hypogammaglobulinemia.ba906885a98782794e154ff1ae99f794946f663e6f601c7b55e0d63fde0369e9.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"pulmonary alveolar proteinosis with hypogammaglobulinemia","paragraphs":["A primarily a lung disorder characterized by onset of respiratory insufficiency due to pulmonary alveolar proteinosis (PAP) in the first months of life. Affected individuals may have normal respiratory function at birth. Development of the disorder appears to be influenced or triggered by viral infection, manifest as progressive respiratory insufficiency, confluent consolidations on lung imaging, and diffuse collection of periodic acid-Schiff (PAS)-positive material in pulmonary alveoli associated with small and nonfoamy alveolar macrophages. Patients also have hypogammaglobulinemia, leukocytosis, and splenomegaly. Many patients die of respiratory failure in infancy or early childhood; hematopoietic stem cell transplantation (HSCT) is curative. The pathogenesis may be related to abnormal function of alveolar macrophages, resulting in decreased catabolism of surfactant. The disorder results from a gain-of-function effect that particularly affects B cells and monocytes."],"scope":"exact","source":"MONDO","upstream":"https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:618042, PMID:29455859","url":"https://monarchinitiative.org/MONDO:0020840"},"ownColumnKeys":["population-b655efa100986cdfbf71"],"publication":"published","relationships":[{"kind":"parent","label":"respiratory system disorder","mondoId":"MONDO:0005087","slug":null},{"kind":"parent","label":"immunodeficiency disease","mondoId":"MONDO:0021094","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"151f7e88f3bbbce9281c476d5f4a61bb45e986e7d2b01fd3bd3b4affea0e8c8a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d4ca6ee8282ffa43d25fa37fc98a78cdfda487fc47426a7f58eea883e68c5da5","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0004313","is_excluded":false,"label":"Decreased circulating immunoglobulin concentration","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d82122cf73d804a7a18b84d7088ea5cd94c043cd4c6546aa9507d7f75dfd8595","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0006517","is_excluded":false,"label":"Intraalveolar phospholipid accumulation","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d91e072fef96d8cb4ff151e4bdf3dc9e2c9454fcb695f5b100520c1c7a3f6359","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e041f39ed502d902c03e5875ffe0ebf747731d5004573a61a7c07c69fd80a88d","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fe60f5362c4e1f79818a752da28600d33d6dbf6d3a53319aecb31ab64987c5c9","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618042","disease_name":"Pulmonary alveolar proteinosis with hypogammaglobulinemia","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"PMID:29455859","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020840\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://orcid.org/0000-0002-7371-8158, https://orcid.org/0000-0003-0113-912X, OMIM:618042, PMID:29455859</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A primarily a lung disorder characterized by onset of respiratory insufficiency due to pulmonary alveolar proteinosis (PAP) in the first months of life. Affected individuals may have normal respiratory function at birth. Development of the disorder appears to be influenced or triggered by viral infection, manifest as progressive respiratory insufficiency, confluent consolidations on lung imaging, and diffuse collection of periodic acid-Schiff (PAS)-positive material in pulmonary alveoli associated with small and nonfoamy alveolar macrophages. Patients also have hypogammaglobulinemia, leukocytosis, and splenomegaly. Many patients die of respiratory failure in infancy or early childhood; hematopoietic stem cell transplantation (HSCT) is curative. The pathogenesis may be related to abnormal function of alveolar macrophages, resulting in decreased catabolism of surfactant. The disorder results from a gain-of-function effect that particularly affects B cells and monocytes.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020840\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pulmonary-alveolar-proteinosis-with-hypogammaglobulinemia","sourceDocuments":[{"name":"MONDO: pulmonary alveolar proteinosis with hypogammaglobulinemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0020840"}],"sourceNote":"","synonyms":["immunodeficiency (due to OAS1 gain-of-function variant) with pulmonary alveolar proteinosis and hypogammaglobulinemia","infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia","OAS1 deficiency","OAS1-related infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia","PAPHG","pulmonary alveolar proteinosis with hypogammaglobulinemia"],"takeawayHtml":"","title":"pulmonary alveolar proteinosis with hypogammaglobulinemia"},"schemaVersion":1}
